Buck Wealth Strategies’s Teva Pharmaceuticals TEVA Stock Holding History

Buck Wealth Strategies’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.6K	Buy	+400	New	+$13.3K	﹤0.01%	542

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

TAM

Todd Asset Management Louisville, Kentucky $5.63B AUM 45.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

KHLMVGHM

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $2.44B AUM 24.95% 1-Year Est. Return

Buck Wealth Strategies's TEVA Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 400 shares worth $13.6K. The stake represents ﹤0.01% of the portfolio and ranks #542 among its holdings.

363 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Buck Wealth Strategies held 400 shares of Teva Pharmaceuticals worth $13.6K as of Q2 2026.
Teva Pharmaceuticals was a new Buck Wealth Strategies position in Q2 2026.
Teva Pharmaceuticals made up ﹤0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #542 holding.
363 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.